Seed Oils and Metabolic Health: A Calm Look at the Evidence

A clinician's calm, apolitical read of what the research actually says about seed oils, linoleic acid, inflammation, and heart risk.

If you have spent time online lately, you have probably run into strong opinions about seed oils. Canola, soybean, sunflower, corn, safflower, the everyday cooking oils, get described as toxic, inflammatory, even a hidden driver of modern disease. Maybe you have started turning bottles over in the grocery aisle, wondering whether the oil in your salad dressing is quietly working against you. That concern is reasonable, and it deserves a calm answer built on evidence rather than a louder opinion. So let me walk through what the research actually shows, where the online story runs ahead of the data, and what a sensible person can do with all of it. I am going to review the claim, not the people making it.

What is a seed oil, and what is linoleic acid?

Seed oils are simply the fats pressed or extracted from seeds and grains. What most of the online debate is really about is one molecule inside them: linoleic acid, an omega-6 polyunsaturated fat. It is an essential fat, meaning your body cannot make it and has to get it from food. The central claim you tend to hear is that linoleic acid is pro-inflammatory in people, and that because modern diets contain much more of it than they used to, it is fueling metabolic disease and heart trouble. It is a tidy story. The question is whether it holds up when you actually test it, and testing it is exactly what a fair amount of research has done.

What do the randomized trials show?

Randomized controlled trials are the closest thing nutrition has to a clean experiment, so start there. A Cochrane systematic review pooled the trials that increased omega-6 fat intake, mainly linoleic acid, and looked at hard outcomes. Higher omega-6 intake made little or no difference to cardiovascular events (relative risk 0.97, 95% confidence interval 0.81 to 1.15) or to all-cause mortality (relative risk 1.00, 95% confidence interval 0.88 to 1.12), with a possible modest reduction in heart attacks (relative risk 0.88, 95% confidence interval 0.76 to 1.02). The certainty of that evidence was rated low to very low, so I would not oversell it in either direction. But the plain reading is important: the trial evidence does not show that more linoleic acid harms the heart.

There is a companion piece worth knowing. When trials replaced saturated fat with polyunsaturated vegetable oil, cardiovascular events fell by roughly 30 percent in an American Heart Association review, an effect the authors described as comparable in size to statin therapy. A separate Cochrane review found that cutting saturated fat lowered cardiovascular events by about 21 percent, with the benefit coming mainly from swapping in polyunsaturated fat rather than from the cut alone. So the picture from randomized trials is neutral to favorable, not harmful.

Does linoleic acid actually raise inflammation?

This is the heart of the online claim, so it deserves a direct look. A systematic review and meta-analysis pooled 30 randomized trials covering 1,377 people and measured what happened to inflammatory markers when dietary linoleic acid went up. Increasing linoleic acid did not significantly change C-reactive protein, and it did not significantly move TNF, IL-6, adiponectin, or MCP-1 either. In other words, when researchers deliberately fed people more of the fat in question and then measured inflammation in the blood, the needle did not move the way the theory predicts. If you want the fuller background on why chronic low-grade inflammation matters and how it is actually driven, I wrote about that in metabolic inflammation.

What about the arachidonic acid mechanism?

The mechanistic argument usually goes like this: linoleic acid converts into arachidonic acid, and arachidonic acid feeds inflammatory pathways, so more linoleic acid must mean more inflammation. It sounds airtight on a whiteboard. Human bodies did not read the whiteboard. A systematic review of 36 human intervention studies found that even large increases in dietary linoleic acid, some in the range of several hundred percent, did not meaningfully raise arachidonic acid levels in plasma, serum, or red blood cells. Only a very small fraction of dietary linoleic acid, on the order of 0.2 percent, is converted to arachidonic acid at all. The proposed pathway simply does not carry the traffic the claim assumes it does.

What do the large population studies suggest?

Now to the observational data, which points the opposite direction from the scary version. An individual-level pooled analysis of 30 prospective cohort studies, roughly 68,000 to 69,000 participants with about 15,000 cardiovascular events across 13 countries, found that higher circulating and tissue levels of linoleic acid were associated with lower risk of major cardiovascular events and death, not higher. A later systematic review reached a similar conclusion: higher linoleic acid intake and biomarker levels tracked with lower total and cardiovascular mortality. A cross-sectional analysis presented at a 2025 nutrition conference also linked higher plasma linoleic acid to a better cardiometabolic profile, including lower glucose, insulin, and inflammatory markers. I want to flag that last one honestly. It was a conference abstract, which means preliminary and not the same weight as a peer-reviewed full paper.

One more caution belongs here, because it cuts both ways. These are associations. People with higher linoleic acid levels may differ in dozens of ways from people with lower levels, and association is not proof of cause. So the fair summary is not that seed oils are protective medicine you should chase. It is narrower and steadier: the specific claim that linoleic acid uniquely drives inflammation and heart disease is not supported, and if anything the biomarker data lean the other way.

Where the real signal actually is

Here is the part I most want you to take home. Most of anyone's seed-oil exposure does not come from a drizzle of oil on roasted vegetables at home. It comes bundled inside fried foods, packaged snacks, and ultra-processed products. Public-health researchers estimate that a very large share of American calories, often cited around 55 to 60 percent, comes from ultra-processed foods. When a food like that is also loaded with refined starch, added sugar, and salt, and is engineered to be easy to overeat, the oil is riding along with a lot of other passengers. Blaming the single ingredient misses the vehicle. If you are curious about that connection, I go deeper in ultra-processed food and in the broader nutrition science behind eating patterns.

So the reasonable focus for lowering inflammation and cardiometabolic risk is the overall pattern and the amount of ultra-processed food, not one bottle in the cupboard. A whole-food pattern does the heavy lifting: vegetables, fruit, legumes, nuts, whole grains, and fish, with less refined grain, added sugar, and processed meat. Within that kind of pattern, ordinary vegetable oils used in moderation, especially in place of saturated fat, fit comfortably in an evidence-based, heart-healthy way of eating.

A reasonable middle you can stand on

If you have felt pulled toward cooking more at home, buying fewer packaged foods, and choosing minimally processed options, that instinct is a good one. It is worth honoring even though the specific "seed oils are poison" version is not backed by the trials. The honest middle is not a counter-crusade in the other direction. Seed oils are not a health tonic, and no one needs to go out of their way to consume more of them. They are just not the villain the loudest posts make them out to be. A related note: oils that are reheated over and over can form oxidation products, but that is a separate question from whether linoleic acid is inflammatory, and it should not be inflated into either a clean bill of health or a panic.

The steadier habit, honestly, is learning to read the science instead of the headline. Effect sizes, confidence intervals, and the difference between a trial and a cross-sectional snapshot tell you far more than a confident thumbnail ever will. I put together some practical ways to do that in making sense of headlines. None of this is a reason to start, stop, or change any prescription on your own, and it is not a substitute for advice from your own clinician. But it is, I hope, a calmer place to stand than the feed. Cook food you enjoy, lean toward whole ingredients, and let the single cooking oil be a small question rather than the whole story.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.